Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01452113
What this trial is testing

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

Who this might be right for
Diabetes Mellitus
University Hospital, Toulouse 21
Large-scale testing (Phase 3)Study completedNCT02104804
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 953
Testing effectiveness (Phase 2)UnknownNCT00836940
What this trial is testing

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Glenmark Pharmaceuticals Europe Ltd. (R&D) 480
Post-approval studies (Phase 4)Study completedNCT02192853
What this trial is testing

Correlation Between Plasma- and Endothelial DPP-4 Activity

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 20
Not applicableStudy completedNCT03817463
What this trial is testing

Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 327,624
Large-scale testing (Phase 3)Study completedNCT02043054
What this trial is testing

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
University of Leicester 90
Large-scale testing (Phase 3)Study completedNCT02015299
What this trial is testing

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
dr. DJ Mulder 45
Large-scale testing (Phase 3)Study completedNCT02314637
What this trial is testing

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 240
Large-scale testing (Phase 3)Study completedNCT02851745
What this trial is testing

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

Who this might be right for
Diabetes Mellitus, Type 2Left Ventricular Systolic Dysfunction
Heart Care Foundation 188
Early research (Phase 1)Study completedNCT00770302
What this trial is testing

Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin

Who this might be right for
Type 2 Diabetes
AstraZeneca 34
Not applicableStudy completedNCT01901861
What this trial is testing

Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Lund University 12
Not applicableStudy completedNCT03793023
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 2,983
Large-scale testing (Phase 3)Study completedNCT00411411
What this trial is testing

Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 49
Large-scale testing (Phase 3)UnknownNCT02250872
What this trial is testing

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

Who this might be right for
CancerCisplatin Adverse Reaction
Seoul National University Bundang Hospital 182
Not applicableStudy completedNCT02737657
What this trial is testing

An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan

Who this might be right for
Diabetes Mellitus, Type 2
Janssen-Cilag International NV 379
Not applicableStudy completedNCT06495281
What this trial is testing

Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 2,044
Not applicableStudy completedNCT01890993
What this trial is testing

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 952
Post-approval studies (Phase 4)Study completedNCT03499704
What this trial is testing

Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Celltrion Pharm, Inc. 133
Large-scale testing (Phase 3)Study completedNCT02022007
What this trial is testing

Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis

Who this might be right for
Polycystic Ovary SyndromeDisorder of Glucose Regulation
Woman's 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07436663
What this trial is testing

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Who this might be right for
Breast Cancer
Tanta University 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation